Autor: |
Qiang Guo, Xin‐Yuan Wang, Yan‐Chang Zhai, Yong‐Wei Dong, Qing‐Si He |
Jazyk: |
angličtina |
Rok vydání: |
2024 |
Předmět: |
|
Zdroj: |
Immunity, Inflammation and Disease, Vol 12, Iss 9, Pp n/a-n/a (2024) |
Druh dokumentu: |
article |
ISSN: |
2050-4527 |
DOI: |
10.1002/iid3.70004 |
Popis: |
Abstract Introduction The purpose of this research was to determine how the P53/microRNA‐34a (miR‐34a)/survivin pathway contributes to oxaliplatin‐induced (L‐OHP) cell inhibition in gastric cancer. Methods The BGC‐823 gastric cancer cells were selected, and we examined their viability following treatment with L‐OHP at different concentrations and time periods. The expression levels of miR‐34a, P53, and survivin in the cells were determined. Results In the 12‐ and 24‐h groups, drug concentration of 15 μg/cm² (p |
Databáze: |
Directory of Open Access Journals |
Externí odkaz: |
|
Nepřihlášeným uživatelům se plný text nezobrazuje |
K zobrazení výsledku je třeba se přihlásit.
|